PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)
Close on Nov 12, 2026Market cap $1.35BP/E –Yield –
PROCEPT BioRobotics cash
Cash and short-term investments held at the end of each period.
PROCEPT BioRobotics's cash was $218.37M at Sep 30, 2026. For fiscal 2025 it was $286.50M, down 14.9% from the year before. The highest annual figure on record is $336.76M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $286.50M | -14.9% |
| FY2024 | Dec 31, 2024 | $336.76M | +30.9% |
| FY2023 | Dec 31, 2023 | $257.22M | +14.0% |
| FY2022 | Dec 31, 2022 | $225.67M | -26.0% |
| FY2021 | Dec 31, 2021 | $305.10M | +202.4% |
| FY2020 | Dec 31, 2020 | $100.91M | +136.2% |
| FY2019 | Dec 31, 2019 | $42.71M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $218.37M | -25.8% |
| Q2 FY2026 | Jun 30, 2026 | $227.91M | -24.7% |
| Q1 FY2026 | Mar 31, 2026 | $245.64M | -22.3% |
| Q4 FY2025 | Dec 31, 2025 | $286.50M | -14.9% |
| Q3 FY2025 | Sep 30, 2025 | $294.28M | +49.6% |
| Q2 FY2025 | Jun 30, 2025 | $302.72M | +41.4% |
| Q1 FY2025 | Mar 31, 2025 | $316.21M | +40.2% |
| Q4 FY2024 | Dec 31, 2024 | $336.76M | +30.9% |
| Q3 FY2024 | Sep 30, 2024 | $196.76M | -31.5% |
| Q2 FY2024 | Jun 30, 2024 | $214.09M | +43.0% |
| Q1 FY2024 | Mar 31, 2024 | $225.58M | +24.6% |
| Q4 FY2023 | Dec 31, 2023 | $257.22M | +14.0% |
| Q3 FY2023 | Sep 30, 2023 | $287.09M | +15.2% |
| Q2 FY2023 | Jun 30, 2023 | $149.69M | -44.5% |
| Q1 FY2023 | Mar 31, 2023 | $180.97M | -36.3% |
| Q4 FY2022 | Dec 31, 2022 | $225.67M | -26.0% |
| Q3 FY2022 | Sep 30, 2022 | $249.22M | -22.2% |
| Q2 FY2022 | Jun 30, 2022 | $269.81M | +69.5% |
| Q1 FY2022 | Mar 31, 2022 | $284.29M | +230.1% |
| Q4 FY2021 | Dec 31, 2021 | $305.10M | +202.4% |
| Q3 FY2021 | Sep 30, 2021 | $320.48M | +182.7% |
| Q2 FY2021 | Jun 30, 2021 | $159.22M | +272.8% |
| Q1 FY2021 | Mar 31, 2021 | $86.12M | – |
| Q4 FY2020 | Dec 31, 2020 | $100.91M | – |
| Q3 FY2020 | Sep 30, 2020 | $113.35M | – |
| Q4 FY2019 | Dec 31, 2019 | $42.71M | – |
See a number that looks wrong?